Page last updated: 2024-09-02

2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine and catechol

2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine has been researched along with catechol in 1 studies

*catechol: RN given refers to unlabeled parent cpd [MeSH]

*catechol: RN given refers to unlabeled parent cpd [MeSH]

Compound Research Comparison

Studies
(2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine)
Trials
(2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine)
Recent Studies (post-2010)
(2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine)
Studies
(catechol)
Trials
(catechol)
Recent Studies (post-2010) (catechol)
10032,1755867

Protein Interaction Comparison

ProteinTaxonomy2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine (IC50)catechol (IC50)
Carbonic anhydrase 1Homo sapiens (human)5.79
Carbonic anhydrase 2Homo sapiens (human)5.79
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)0.868
Carbonic anhydrase 6Homo sapiens (human)5.79
Glutaminyl-peptide cyclotransferaseHomo sapiens (human)5
Carbonic anhydrase 3Bos taurus (cattle)5.79

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, H; Mitsumori, K; Morita, R; Shibutani, M; Suzuki, K; Taniai, E; Yafune, A1

Other Studies

1 other study(ies) available for 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine and catechol

ArticleYear
Aberrant activation of M phase proteins by cell proliferation-evoking carcinogens after 28-day administration in rats.
    Toxicology letters, 2013, Jun-07, Volume: 219, Issue:3

    Topics: Animals; Aurora Kinase B; Aurora Kinases; Biomarkers; Butylated Hydroxyanisole; Carcinogens; Catechols; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Division; Cell Proliferation; Chromobox Protein Homolog 5; Chromosomal Proteins, Non-Histone; Cyclin-Dependent Kinases; Histones; Imidazoles; Isothiocyanates; Male; Precancerous Conditions; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred F344; Sulfadimethoxine

2013